r.hu-Erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline

BACKGROUND: As EPO treatment of chronic anemia of advanced renal disease is now the standard of care we examined if such treatment may slow the progression of renal function decline. METHODS: Data of 18 pre-ESRD patients were analyzed retrospectively 12 months prior and prospectively 12 months after...

Descripción completa

Detalles Bibliográficos
Autores principales: Tapolyai, Mihály, Kadomatsu, Satoshi, Perera-Chong, Manuel
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC165597/
https://www.ncbi.nlm.nih.gov/pubmed/12809563
http://dx.doi.org/10.1186/1471-2369-4-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC165597/
https://www.ncbi.nlm.nih.gov/pubmed/12809563
http://dx.doi.org/10.1186/1471-2369-4-3

Ejemplares similares